Alerts will be sent to your verified email
Verify EmailALEMBICLTD
Alembic
|
Marathon NextgenReal
|
Hubtown
|
|
---|---|---|---|
Operational Metrics
|
|||
Pharmaceutical Sector
|
|||
Domestic Sales Growth - YoY
|
10.3 % | n/a | n/a |
R&D as a % of Total Sales
|
0.06 % | n/a | n/a |
Financials
|
|||
5 yr Average ROE
|
13.7 % | 8.92 % | -5.37 % |
5yr average Equity Multiplier
|
1.05 | 2.76 | 3.4 |
5yr Average Asset Turnover Ratio
|
0.05 | 0.21 | 0.06 |
5yr Avg Net Profit Margin
|
303.17 % | 14.1 % | -31.58 % |
Price to Book
|
1.21 | 2.54 | 1.22 |
P/E
|
8.68 | 15.94 | 0.0 |
5yr Avg Cash Conversion Cycle
|
79.64 Days | 281.42 Days | 3206.91 Days |
Inventory Days
|
237.67 Days | 573.67 Days | 2832.21 Days |
Days Receivable
|
50.07 Days | 35.67 Days | 278.51 Days |
Days Payable
|
292.14 Days | 181.55 Days | 555.22 Days |
5yr Average Interest Coverage Ratio
|
181.25 | 2.02 | 0.21 |
5yr Avg ROCE
|
4.08 % | 10.41 % | 1.64 % |
5yr Avg Operating Profit Margin
|
20.81 % | 29.69 % | -9.01 % |
5 yr average Debt to Equity
|
0.0 | 1.14 | 0.59 |
5yr CAGR Net Profit
|
-3.98 % | 47.21 % | 7.07 % |
5yr Average Return on Assets
|
13.04 % | 3.45 % | -1.57 % |
Shareholdings
|
|||
Promoter Holding
|
70.88 % | 73.63 % | 32.09 % |
Share Pledged by Promoters
|
0.0 | 91.46 % | 26.83 % |
Change in Promoter Holding (3 Yrs)
|
0.0 | -1.34 % | -11.77 % |
Change in Mutual Fund Holding (3 Yrs)
|
-4.63 % | 2.42 % | 0.0 |
Alembic
|
Marathon NextgenReal
|
Hubtown
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
-
|
-
|
Asset Break-Up
|
Asset Break-Up
|
-
|
-
|